Navigation Links
Enox Biopharma, Inc. Expands Its Technology to Cover the Wound Care Market
Date:5/31/2011

VANCOUVER, British Columbia, May 31, 2011 /PRNewswire/ -- Enox Biopharma, Inc., a leader in the development of innovative solutions for infections associated with medical devices, today announced that it has expanded its technology to cover the wound care market by filing a patent application on novel means of delivering nitric oxide directly to wounds.

Nitric oxide is well recognized as both an antimicrobial agent which can prevent infections and as a vasodilator which can accelerate wound healing. The unstable nature of nitric oxide has, until now, prevented its clinical use. Enox Biopharma has already protected the dosing of polymers with nitric oxide which is sequestered in the polymer in a stable state. The nitric oxide remains in the polymer until it is used clinically at which point it emits nitric oxide over the period of weeks. Our new technology allows us to deliver nitric oxide directly to wounds which may prevent infections while expediting the healing process ultimately facilitating the closing of chronic wounds that would not otherwise heal.

"The inability to heal foot ulcers in the diabetic patient leads to over one million leg amputations per year according to the World Diabetes Foundation," noted Enox's founder and President Professor Yossef Av-Gay. "It is conceivable that we could replace this gruesome standard of care with a noninvasive nitric oxide delivery method. It will take time and clinical research to determine if this is indeed possible but the potential is certainly there."

John Rewcastle, Ph.D., Chief Executive Officer of Enox, commented, "The wound care market is drastically underserved today. Although we can't yet fully disclose the details of our patent application, we believe the novel delivery method, which we are in the process of fully protecting globally will meet the need of millions of patients worldwide. We are excited to contribute to the wound care market which is expected to exceed twenty billion do
'/>"/>

SOURCE Enox Biopharma, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. PDL BioPharma, Inc. Announces Proposed $135 Million Public Offering of New Convertible Senior Notes Due 2015
2. Enox Biopharma, Inc. Appoints Dr. John Rewcastle as CEO
3. Sinobiopharma, Inc. Appoints New Director of Marketing
4. Thomas K. Equels Elected to Hemispherx BioPharma, Inc. Board of Directors
5. BioStorage Technologies Expands U.S. Operations with Opening of New Biorepository Facility
6. DATATRAK Academy Expands to Include Durham Technical Community College
7. Clinical Site Services Expands to Provide Global Patient Enrollment Services to Rest-of-World
8. Practice Fusion Expands Executive Team with New VP of Marketing and Senior Business Development Director
9. Online Career Service for Postgraduate Life Scientists Expands Membership to Individuals
10. GeneWize Expands DNA Customization into 3 Mega Markets
11. China-Biotics Expands Product Supplied to Bright Dairy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... This webinar will focus on EMA and ... in biosimilars. , Regulatory frameworks are evolving many countries ... the complex nature of biopharmaceuticals makes the demonstration of ... challenging. Based on the specific aspects of biosimilar drug ...
(Date:1/15/2014)... (PRWEB) January 15, 2014 More than ... and about 1 in 3 seniors will die with ... ). These jaw-dropping figures have shocked many Americans into ... hopefully, help prevent these tragic age-related cognitive disorders. Jonathan ...
(Date:1/15/2014)... The Microcompetition with Foreign DNA theory explains how ... latent viruses is the Epstein Barr Virus (EBV), and one ... is a chronic inflammatory disease that destroys the body’s joints. ... patients have high concentrations of EBV DNA in their bodies ...
(Date:1/15/2014)... January 15, 2014 2013 was a ... Brain State Technologies®. They saw continued independent research led ... who were awarded a $1 million grant from the ... “Brain and Behavior” a peer reviewed journal, Amy Grant ...
Breaking Biology Technology:Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2Biohack Pure Offers 5 Tips for Increasing Memory in 2014 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 2Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 3
... , SAN DIEGO, July 30 Cardium ... to develop a DNA-based orthobiologics product portfolio based on research ... focus on non-union bone fractures for medically-compromised patients, and spinal ... a rapidly growing segment of the orthopedics market and represents ...
... , NEW YORK, July 30 Stemline Therapeutics, ... of oncology compounds directed to cancer stem cell targets, today ... invited to present at the New Frontiers in Cancer Drug ... Development Week in Boston, MA. Dr. Bergstein,s presentation, entitled ...
... July 30 /PRNewswire-Asia-FirstCall/ -- Lotus Pharmaceuticals, Inc.,(OTC Bulletin ... developer and,producer of prescriptions drugs and licensed national ... China, today reported it received notice,of patent pending ... People,s,Republic of China for its innovative patent application ...
Cached Biology Technology:Cardium Announces New Orthobiologics Product Initiative Extending Gene Activated Matrix Technology to Deliver Bone Growth Factors 2Cardium Announces New Orthobiologics Product Initiative Extending Gene Activated Matrix Technology to Deliver Bone Growth Factors 3Cardium Announces New Orthobiologics Product Initiative Extending Gene Activated Matrix Technology to Deliver Bone Growth Factors 4Cardium Announces New Orthobiologics Product Initiative Extending Gene Activated Matrix Technology to Deliver Bone Growth Factors 5Cardium Announces New Orthobiologics Product Initiative Extending Gene Activated Matrix Technology to Deliver Bone Growth Factors 6Cardium Announces New Orthobiologics Product Initiative Extending Gene Activated Matrix Technology to Deliver Bone Growth Factors 7Cardium Announces New Orthobiologics Product Initiative Extending Gene Activated Matrix Technology to Deliver Bone Growth Factors 8Cardium Announces New Orthobiologics Product Initiative Extending Gene Activated Matrix Technology to Deliver Bone Growth Factors 9Cardium Announces New Orthobiologics Product Initiative Extending Gene Activated Matrix Technology to Deliver Bone Growth Factors 10Stemline Therapeutics CEO to Present at IBC's New Frontiers in Cancer Drug Development Conference 2Lotus Pharmaceuticals, Inc. Announces Patent Pending Gliclazide-Controlled Release Tablets 2Lotus Pharmaceuticals, Inc. Announces Patent Pending Gliclazide-Controlled Release Tablets 3
(Date:4/17/2014)... are implicated in many serious conditions such as heart ... target for drug therapies. Unfortunately, there is still much ... research provides fresh and unexpected insight into the structure ... - β-subunit molecules - which are responsible for ,fine-tuning, ... in the most recent edition of the Journal ...
(Date:4/17/2014)... is the process whereby the genetic information of ... as proteins, which have numerous different functions in ... important intermediary during gene expression, by relating the ... involved in manufacturing proteins. , By examining ... present in an organism at a given time, ...
(Date:4/17/2014)... by the Australian National University (ANU), have developed ... deep-sea temperature variability over the past 5.3 million ... the climate surrounding ice ages over the past ... relationship between carbon dioxide levels, global temperatures and ... of Southampton (UoS) and the National Oceanography Centre ...
Breaking Biology News(10 mins):Structure of sodium channels different than previously believed 2Rapid and accurate mRNA detection in plant tissues 2Ancient sea-levels give new clues on ice ages 2
... through his handmade microscope in 1702, it was Anton van ... He observed the rapid contraction of a stalk tethering the ... surface of a leaf. Little did van Leeuwenhoek imagine that ... Vorticella would set records for speed and power in the ...
... led by scientists at Memorial Sloan-Kettering Cancer Center have discovered ... stage clinical trials -- work best in patients with mutations ... a central role in the growth and survival of cancer ... melanoma and in a minority of patients with colon, breast, ...
... College of Neuropsychopharmacology's Annual Meeting revealed that scientists have ... cognition. The study, which was funded by the ... of Pittsburgh, is among the first to identify genetic ... aging has been defined in many ways, we focused ...
Cached Biology News:Nano springs eternal; Protozoan 'engine' posts nano records 2Mutations in the BRAF gene predict sensitivity to a novel class of cancer drugs 2New research examines genetics of successful aging 2
... in a regulated environment, Pipette Tracker ... software that automates gravimetric pipette calibration ... that meets todays regulatory compliance requirements. ... solution that includes a full security ...
... AAIPharmas Routine Testing Laboratory (RTL) ... developed over 25 years. ,,Microbial method ... used to monitor the conditions of ... quality for manufactured products,,We offer a ...
... Research Scale (gram quantities of IgY) , ... Prepare your Antigen), we segregate the appropriate number ... After 3 such eggs are collected (usually over ... injection series. This involves a total of four ...
... cDNA Library Panels were designed for full-length ... of PCRs to identify the desired cDNA ... in a 96-well "Master Plate," where each ... Having identified the positive well(s) by gel ...
Biology Products: